POSB161 Cost-Effectiveness of Dapagliflozin Plus Standard Treatment Compared to Standard Treatment for the Management of Heart Failure with Reduced Ejection Fraction in Colombia
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.434
https://www.valueinhealthjournal.com/article/S1098-3015(21)02229-4/fulltext
Title :
POSB161 Cost-Effectiveness of Dapagliflozin Plus Standard Treatment Compared to Standard Treatment for the Management of Heart Failure with Reduced Ejection Fraction in Colombia
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02229-4&doi=10.1016/j.jval.2021.11.434
First page :
Section Title :
Open access? :
No
Section Order :
11214